ArticleCancers2019

Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial.

Fatéméh Dubois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.